UW Medicine, Fred Hutch scientists will jointly test whether the monoclonal drug can prevent infection among people exposed to COVID-19.

Researchers at UW Medicine and the Fred Hutchinson Cancer Research Center are jointly testing monoclonal antibodies created by Regeneron Pharmaceuticals to prevent COVID-19, and are starting to recruit patients.

Subscribe for daily reports delivered to your inbox here.

By Sandi Doughton Seattle Times staff reporter

Born during the Second Congo War, Sabrina Ebengho grew up in Équateur​ province in the Democratic Republic of the Congo (DRC) before immigrating to the United States at the age of 13. Sabrina  is now pursuing her education at the University of Washington, and is among the first undergraduate Public Health-Global Health majors completing the Global Health option. In the future, she seeks to improve access to quality healthcare for all in the DRC and beyond, focusing on women, adolescents, and children’s health, and education.

The University of Washington MetaCenter for Pandemic Preparedness, a collaboration of scientific experts from 11 UW organizations, has announced today that the initiative will change its name and will be known as the UW Alliance for Pandemic Preparedness, effective immediately. The renaming reflects the evolution of the initiative and its vision for the future.